In recent years, TIM-3 and Alzheimer's disease have emerged as critical focal points in the quest to understand and combat neurodegenerative diseases.Research led by experts like Vijay Kuchroo has uncovered the potential of TIM-3 as a checkpoint molecule that inhibits the activity of microglia, the brain's immune cells.